Elotuzumab Intravenous and NovoLog PenFill
Determining the interaction of Elotuzumab Intravenous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: elotuzumab
Brand name: Empliciti
Synonyms: Elotuzumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Elotuzumab Intravenous-Novoseven
- Elotuzumab Intravenous-NovoSeven RT
- Elotuzumab Intravenous-NovoSeven RT with MixPro injection
- Elotuzumab Intravenous-Novothyrox
- Elotuzumab Intravenous-Noxafil
- Elotuzumab Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Eloxatin
- NovoLog PenFill-Elppa CoQ10 coenzyme Q-10
- NovoLog PenFill-Elspar
- NovoLog PenFill-Elta SilverGel
- NovoLog PenFill-Elta Tar
- NovoLog PenFill-Eltrombopag